Publication(s) | Cohort | Determination of CKD | Prevalence of CKD stages 3–5 |
---|---|---|---|
Stevens 2007 | 130,266 patients from GP practices in Kent, Manchester and Surrey, aged 18 and over | Single eGFR (MDRD) determined from calibrated creatinines | 8.5% |
de Lusignan 2011, Kearns 2013 | Up to 930,977 patients from practices in the Quality Improvement in CKD study (QICKD), aged 18 and over | Various methods including single and multiple eGFR readings (MDRD and CKD-EPI) | 4.8–6.8% |
Roderick 2011, Fraser 2015 | Data from the Health Survey for England 2009–2010, involving more than 6000 participants, aged 16 and over | Single eGFR reading (MDRD and CKD-EPI) in combination with urine estimation of albuminuria | 5.2–6.0% |
Jameson 2014 | Approximately 2.8 million individuals in the General Practice Research Database (GPRD), aged 18 and over | Two laboratory eGFR readings at least 90 days apart (MDRD) and Read diagnostic codes | 5.9% |
Jain 2014 | Data from The Health Improvement Network (THIN) database, comprising 2,707,130 patients from 426 GP practices, aged 18 and over | 2 most recent laboratory eGFR readings taken at least 7 days apart (MDRD) and Read diagnostic codes | 4.0% |
NCKDA 2016 | Data from 911 GP practices from England and Wales, encompassing 5.2 million adults | Two eGFR calculations at least 90 days apart (MDRD), Read diagnostic codes | 5.5% |